fMRI and Opioid Abstinence — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

fMRI and Opioid Abstinence — Stella

Recruiting

Back to Drug Use Disorder trials

Trial locations(1 site)

United States

The APT Foundation, New Haven, Connecticut

Key details

Sponsor

Yale University

Collaborators

National Institute on Drug Abuse (NIDA)

Enrollment target

~240 participants

Started

December 2024

Primary completion

November 2029

Age range

18 Years – 50 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov